RECOVERY - Delivery Order Notification THIS NOTICE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY UNDER THE AMERICAN RECOVERY AND REINVESTMENT ACT PROGRAM. The Centers for Disease Control and Prevention (CDC) intends to issue a delivery order against an Indefinite Delivery Indefinite Quantity Contract 200-2010-33945 to GlaxoSmithKline Holdings (Americas) Inc. (GSK) for the following vaccines: Vaccine Estimated $" Value DTAP $ 44,359 DTAPHBIP $ 228,640 DTaPIPV $ 82,868 HEP A $ 213,734 HEP B-PF $ 324,292 HIB $ 19,087 HPV $ 114,284 ROTA $ 651,018 TDAP $ 2,653,813 HEP AB18 $ 11,993 DTAP $ 44,359 Total $ 4,388,447 The delivery order will be funded through the American Recovery and Reinvestment Act of 2009. This opportunity is available only to contractor GSK under Contract Number 200-2010-33945, which was previously competed and awarded in March 2010. This is not a request for competitive proposals, nor is a solicitation available. This notice is provided for informational purposes under the American Recovery and Reinvestment Act (ARRA) Program. Any questions regarding this notice must be submitted in writing to Berta Biltz at
[email protected] .